References
- ANON., 1994, TDx Assays Manual (Abbott Park: Abbott Laboratories).
- BACHMANN, K. and Gilosx, R., 2001, The use of in vitro methods to predict in vivo pharmacokinetics and drug interactions. Current Drug Metabolism, 2, 299–314.
- BORCHARDT, R. T., 2001, Integrating drug discovery and development. Scientist, 15, 43.
- EKINS, S., RING, B., GRACE, J., MCROBIE-BELLE, D. and WRIGHTON, S. J., 2000, Present and future in vitro approaches for drug metabolism. Journal of Pharmacological and Toxicological Methods, 44, 313–324.
- HASSOUN, E. A., ROCHE, V. F. and STOHS, S. J., 1993, Release of enzymes by ricin from macrophages and Chinese hamster ovary cells in culture. Toxicology Methods, 3, 119–129.
- IWATSUBO, T., HIROTA, N., 001E, T., SUZUKI, H., SHIMADA, N., CHIBA, K., ISHIZAKI, T., GREEN, C. E., TYSON, C. A. and SUGIYAMA, Y., 1997, Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data. Pharmacology and Therapeutics, 73, 147–171.
- LIPINSKI, C. J., 2000, Drug-like properties and the causes of poor solubility and poor permeability. Pharmacology and Toxicological Methods, 44, 235–249.
- Moss, D. W., HENDERSON, A. R. and KACHMAR, J. R., 1986, Enzymes. In N. W. Tietz (ed.), Textbook of Clinical Chemistry (Philadelphia: W. B. Saunders), pp. 619–663.
- OBACH, R. S., 1999, Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes. Drug Metabolism and Disposition, 27, 1350–1359.
- OBACH, R. S., BAXTER, J., LISTON, T., SILBER, B., JoNEs, B., MACINTYRE, F., RANCE, D. and WASTALL, P., 1997, The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data. Journal of Pharmacology and Experimental Therapeutics, 283, 46–58.
- BRENT'S, R., Lis, Y. and WALKER, S., 1988, Pharmaceutical innovation by seven UK owned companies (1964–1985). British Journal of Clinical Pharmacology, 25, 387–396.
- SHIBATA, Y., TAKAHASHI, H. and Ism', Y., 2000, A convenient in vitro screening method for predicting in vivo metabolic clearance using isolated hepatocytes suspended in serum. Drug Metabolism and Disposition, 28, 1518–1523.
- THUMMEL, K. and SHEN, D., 2001, Design and optimisation of dosage regimens: pharmacokinetic data. In J. G. Hardman, L. E. Limbird and A. Goodman Gilman (eds), Goodman CI Gilman's The Pharmacological Basis of Therapeutics (New York: McGraw Hill), pp. 1917–2023.
- VENKATAKRISHNAN, K., VON MOLTKE, L., COURT, M., HARMATZ, J., CRESI, C. and GREENBLATT, D., 2000, Comparison between cytochrome P450 (CYP) content and relative activity approaches to scaling from cDNA-expressed CYPs to human liver microsomes: ratios of accessory proteins as sources of discrepancies between the approaches. Drug Metabolism and Disposition, 28, 1493–1504.